ScholarIQanswers from OpenAlex

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12

PaperCitations, authors & open-access status

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 have?

ScholarIQcitation count

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 has 91 citations in the OpenAlex counts ScholarIQ stores.

When was Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 published?

ScholarIQyear

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 has 1999 year in the ScholarIQ index.

What is the open-access status of Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12?

ScholarIQoa status

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 has green oa status in the ScholarIQ index.

What is the DOI of Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12?

ScholarIQdoi

The DOI for Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 is on the source record.

What is the PMID of Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12?

ScholarIQpmid

The PMID for Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 is on the source record.

What is the OpenAlex record for Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12?

ScholarIQopenalex

The OpenAlex for Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial